M P Okamoto1, R K Nakahiro. 1. Department of Pharmacy Practice and Social and Administrative Sciences, Western University of Health Sciences, Pomona, California 91766, USA. mokamoto@westernu.edu
Abstract
STUDY OBJECTIVE: To measure clinical, economic, and humanistic outcomes associated with a pharmacist-managed hypertension clinic compared with physician-managed clinics. DESIGN: Prospective, randomized, comparative study. SETTING: Managed care organization. PATIENTS: A total of 330 patients with mild-to-moderate essential hypertension. INTERVENTION: Hypertension care provided by either the pharmacist-managed hypertension clinic or physician-managed general medical clinics. MEASUREMENTS AND MAIN RESULTS: Baseline and 6-month evaluations consisted of systolic and diastolic blood pressure measurements, a short-form health survey, and collection of health care utilization information. After treatment, blood pressure measurements were significantly lower (p<0.001) in the pharmacist-managed hypertension clinic group than in the physician-managed clinic group. Patient satisfaction was significantly higher in the hypertension clinic group. Total costs for the hypertension clinic group were not different from those of the physician-managed clinic group ($242.46 vs $233.20, p=0.71), but cost:effectiveness ratios were lower in the hypertension clinic group ($27 vs $193/mm Hg for systolic blood pressure readings, and $48 vs $151/mm Hg for diastolic blood pressure readings). CONCLUSION: In a hypertension clinic, pharmacists can be a cost-effective alternative to physicians in management of patients, and they can improve clinical outcomes and patient satisfaction.
RCT Entities:
STUDY OBJECTIVE: To measure clinical, economic, and humanistic outcomes associated with a pharmacist-managed hypertension clinic compared with physician-managed clinics. DESIGN: Prospective, randomized, comparative study. SETTING: Managed care organization. PATIENTS: A total of 330 patients with mild-to-moderate essential hypertension. INTERVENTION: Hypertension care provided by either the pharmacist-managed hypertension clinic or physician-managed general medical clinics. MEASUREMENTS AND MAIN RESULTS: Baseline and 6-month evaluations consisted of systolic and diastolic blood pressure measurements, a short-form health survey, and collection of health care utilization information. After treatment, blood pressure measurements were significantly lower (p<0.001) in the pharmacist-managed hypertension clinic group than in the physician-managed clinic group. Patient satisfaction was significantly higher in the hypertension clinic group. Total costs for the hypertension clinic group were not different from those of the physician-managed clinic group ($242.46 vs $233.20, p=0.71), but cost:effectiveness ratios were lower in the hypertension clinic group ($27 vs $193/mm Hg for systolic blood pressure readings, and $48 vs $151/mm Hg for diastolic blood pressure readings). CONCLUSION: In a hypertension clinic, pharmacists can be a cost-effective alternative to physicians in management of patients, and they can improve clinical outcomes and patient satisfaction.
Authors: Verughese Jacob; Sajal K Chattopadhyay; Anilkrishna B Thota; Krista K Proia; Gibril Njie; David P Hopkins; Ramona K C Finnie; Nicolaas P Pronk; Thomas E Kottke Journal: Am J Prev Med Date: 2015-11 Impact factor: 5.043
Authors: Katherine T Mills; Katherine M Obst; Wei Shen; Sandra Molina; Hui-Jie Zhang; Hua He; Lisa A Cooper; Jiang He Journal: Ann Intern Med Date: 2017-12-26 Impact factor: 25.391
Authors: Jan D Hirsch; Neil Steers; David S Adler; Grace M Kuo; Candis M Morello; Megan Lang; Renu F Singh; Yelena Wood; Robert M Kaplan; Carol M Mangione Journal: Clin Ther Date: 2014-07-30 Impact factor: 3.393